Document is current
Any future updates will be listed below
-
Authors
Ma, Xingcong
Shou, Peishun http://orcid.org/0000-0001-7685-7471
Smith, Christof
Chen, Yuhui
Du, Hongwei
Sun, Chuang
Porterfield Kren, Nancy
Michaud, Daniel
Ahn, Sarah
Vincent, Benjamin
Savoldo, Barbara
Pylayeva-Gupta, Yuliya
Zhang, Shuqun
Dotti, Gianpietro http://orcid.org/0000-0002-2639-8526
Xu, Yang http://orcid.org/0000-0003-1468-2703
-
Funding
Funding for this research was provided by:
U.S. Department of Defense (W81XWH1810441)
U.S. Department of Health & Human Services | National Institutes of Health (1R37CA230786-01A1-01A1)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01-CA193140-03)
- License Information
-
More Information
Article History
Received: 25 January 2019
Accepted: 17 December 2019
First Online: 3 February 2020
Competing interests
: G.D. and B.S. have sponsored research agreements with Bluebird Bio, Cell Medica and Bellicum Pharmaceutical. G.D. serves on the scientific advisory board of MolMed and Bellicum Pharmaceutical.
